Viome Acquires Circulate Health, Closing the Loop Between Early Chronic Disease Diagnostics, Precision Nutrition & Treatment

Viome Life Sciences acquired Circulate Health, which provides therapeutic plasma exchange (TPE) outside hospital settings. Circulate Health’s protocols address health span, chronic disease, and the reduction of microplastics in the body. Financial terms were not disclosed.

TPE is a medical procedure used in hospitals for more than 50 years to treat certain autoimmune and neurological conditions. Circulate Health applied the procedure in longevity-focused care and contributed to research on its potential uses.

Viome provides molecular diagnostic and precision nutrition services intended to help health care professionals assess biological aging, inflammation, metabolism, and the microbiome. The company plans to . . .